dc.contributor.author |
Green, Robin J.
|
|
dc.contributor.author |
Zar, Heather J.
|
|
dc.contributor.author |
Bateman, E.D.
|
|
dc.date.accessioned |
2007-07-20T12:27:55Z |
|
dc.date.available |
2007-07-20T12:27:55Z |
|
dc.date.issued |
2007-03 |
|
dc.description.abstract |
Advances in asthma management, particularly the introduction
of controller medication of which inhaled corticosteroids are
the most important, has resulted in a steady decline in asthma
mortality in most countries. This is usually accompanied
by a decline in episodes of near-fatal asthma attacks and
hospitalisations, and a reduction in other indicators of asthma
morbidity. These gains have led to a shift in thinking on
the management of asthma, away from simply preventing
death and hospitalisations, toward achieving and maintaining
sustained control of all clinical features. |
en |
dc.format.extent |
807606 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.identifier.citation |
Green, RJ, Zar, HJ & Bateman, ED 2007,'Asthma - is survival good enough?', South African Medical Journal, vol. 97, no. 3, pp. 172-174. [http://www.journals.co.za/ej/ejour_m_samj.html] |
en |
dc.identifier.issn |
0038-2469 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/3088 |
|
dc.language.iso |
en |
en |
dc.publisher |
South African Medical Association |
en |
dc.rights |
South African Medical Association |
en |
dc.subject |
South Africa |
en |
dc.subject |
Prevention and control |
en |
dc.subject |
Disease management |
en |
dc.subject |
Asthma |
en |
dc.subject.lcsh |
Asthmatics |
|
dc.subject.lcsh |
Adrenocortical hormones |
|
dc.subject.lcsh |
Disease management |
|
dc.subject.lcsh |
Medicine, Preventive |
|
dc.title |
Asthma - is survival good enough? |
en |
dc.type |
Article |
en |